[Characteristics of drug-induced hepatitis in patients with tuberculosis].
D000636:Aminosalicylic Acids / Q000009:adverse effects; D000995:Antitubercular Agents / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis*; D005000:Ethionamide / Q000009:adverse effects; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects; D008099:Liver / Q000187:drug effects*; D011718:Pyrazinamide / Q000009:adverse effects; D013307:Streptomycin / Q000009:adverse effects; D013828:Thioacetazone / Q000009:adverse effects; D014376:Tuberculosis / Q000188:drug therapy
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D011718:Pyrazinamide; D013828:Thioacetazone; D005000:Ethionamide; D007538:Isoniazid; D013307:Streptomycin
K kharakteristike lekarstvennykh gepatitov u bol'nykh tuberkulezom.